Epidiolex is the first Food and Drug Administration (FDA) approved medication that includes its key active ingredient cannabidiol (CBD). Two severe cases of epilepsy are licensed for use as a treatment: Lennox-Gastaut syndrome and Dravet syndrome. It is mainly for use by children two years and older.
In 2018, Epidiolex was the first pure CBD-based medication ever to obtain FDA approval in America. This is undoubtedly exciting, but it is always good to understand what medication is. Here’s what you should know about Epidiolex.
What is Epidiolex?
In 2018, Epidiolex was officially approved by the FDA. It is an oral solution designed to treat seizures associated with two rare and severe epilepsy types: Lennox-Gastaut syndrome and Dravet syndrome (also known as severe myoclonic epilepsy in children). The drug was approved for patients aged more than two years.
Epidiolex was the first FDA-licensed drug for treating patients with Dravet syndrome and the first CBD-based medication approved by the federal body, marking a significant milestone for the company and the introduction of CBD to many people as a potential therapeutic aid.
Is there a list of ingredients?
-
F.A.S.T. + F.A.S.T. Load 25mg CBD Double Pack
$29.95 Add to cart -
Cannabidiol Oral Solution
$31.95 Add to cart -
CBD Softgels for Sleep
From: $33.95 Select options This product has multiple variants. The options may be chosen on the product page
CBD’s beneficial effects have long been documented in potentially helping alleviate stress, among other potential benefits. So due to this, the usage of CBD-based drugs has been approved by 29 jurisdictions to support the sufferers with such diseases that could be helped by the medications. As the research on CBD is still preliminary, we are still trying to understand its effects.
Due to that, Epidiolex approval by the FDA creates a stable base for the sector and now needs to adopt a standard of effective and efficient CBD medication. This makes it easier for those who need it to get their hands on safely processed CBD products. So, Epidiolex is a standard to adopt for potential new CBD-based medicines.
The main ingredients are as follows:
CBD:
CBD is one of several cannabinoids or organic substances present in hemp and marijuana.
Sesame seed oil:
Sesame oil is a vegetable oil that is edible from sesame seeds. In addition to being used as cooking oil, it is often employed in many cuisines as a spice enhancer, with a distinctive nutty scent and taste. It is also used in many medicines.
Sucralose:
Sucralose is an artificial sweetener and a supplement for sugar. The body doesn’t break down the rest of swallowed sucralose because it becomes non-caloric.
Final thoughts:
The announcement of Epidiolex’s acceptance arrived for us as supporters of all things of cannabis is nothing short of celebratory. CBD consumers around the globe who are living and dealing with uncommon cases of epilepsy will finally gain exposure to medication that transforms their lives!
